搜尋結果
- 20.50-0.12 (-0.58%)2024/07/17 16:22 臺灣股市 已收盤 (報價延遲20分鐘)。
- 昨收20.62開盤20.69委買價20.50委賣價20.51
- 今日價格區間20.50 - 20.6952週價格區間16.01 - 21.87成交量208837 張平均成交量135298 張
- 市值不適用本益比 (最近12個月)不適用營運報告/法說會日期不適用除權除息日-
相關股票
2024年6月7日 · Soliris and Ultomiris are C5 inhibitors and work by binding to the complement protein C5 for the treatment of PNH. Blocking two complement pathways at Factor D (with Voydeya) and C5 (with Soliris) may be an effective treatment approach patients with PNH who experience EVH.